Srovnání vaginálního užití mikronizovaného progesteronu k luteální podpoře. Randomizovaná studie porovnávající Utrogestan a Crinone 8
[Comparison of vaginal use of micronized progesterone for the luteal support. Randomized study comparison of Utrogestan and Crinone 8]
Language Czech Country Czech Republic Media print
Document type Journal Article, Randomized Controlled Trial
PubMed
28252308
PII: 60463
- Keywords
- luteal phase support IVF/ET.,
- MeSH
- Administration, Intravaginal MeSH
- Adult MeSH
- Fertilization in Vitro * MeSH
- Sperm Injections, Intracytoplasmic * MeSH
- Humans MeSH
- Luteal Phase MeSH
- Embryo Transfer * MeSH
- Progesterone analogs & derivatives therapeutic use MeSH
- Progestins therapeutic use MeSH
- Prospective Studies MeSH
- Pregnancy MeSH
- Pregnancy Rate * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
- Names of Substances
- Crinone MeSH Browser
- Progesterone MeSH
- Progestins MeSH
OBJECTIVE: The study was focused on comparison of efficiency, safety and tolerance of vaginal use of micronized progesterone in preparations Utrogestan and Crinone 8%. DESIGN: Prospective randomized study. SETTING: Department of Gynecology and Obstetric, University Hospital, Olomouc, Faculty of Medicine and Dentistry, Palacky University, Olomouc. MATERIAL AND METHODOLOGY: Into a prospective randomized study was, after calculation of 80% of the power of the study, α = 0,05, included 111 women in age between 18-40 with a basal value FSH < 10 IU/l and a normal finding in uteral cavity. After evaluation of efficiency of both preparations there was selected a fertilization rate, an implantation rate, a pregnancy rate and a take-home baby rate. Comparison of tolerance was made from evaluation of 21 parameters which were obtained through a questionnaire. RESULTS: There were not been proven any significant differences in efficiency between both preparations. Crinone 8% was in patients better tolerated. CONCLUSION: Luteal support within the IVF/ICSI-ET remains an integral part of the treatment. According to the outcomes of the study it seems to be more suitable to use a vaginal gel for the luteal support with micronized progesterone.